Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryusuke Hayashi

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Head & Neck|October 5, 2020
Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapyMichihisa Kono, Risa Wakisaka, Takumi Kumai, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2023
Cholinergic sensing of allergen exposure by airway epithelium promotes type 2 immunity in the lungsRyusuke Hayashi, Yotesawee Srisomboon, Koji Iijima, et al.
Cancer Research Communications|June 10, 2026
Peptide-reactive T cell response as a novel biomarker in head and neck cancer patients treated with anti-PD-1 antibodyTakumi Kumai, Shota Sakaue, Hisataka Ominato, et al.
Biochemical and Biophysical Research Communications|November 28, 2019
Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinomaShohei Harabuchi, Akemi Kosaka, Yuki Yajima, et al.
Schizophrenia Bulletin|December 21, 2022
Disorganization of Semantic Brain Networks in Schizophrenia Revealed by fMRIYukiko Matsumoto, Satoshi Nishida, Ryusuke Hayashi, et al.
Translational Oncology|February 5, 2022
IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancerMichihisa Kono, Hidekiyo Yamaki, Hiroki Komatsuda, et al.
Cancer Science|October 26, 2022
Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulationHiroki Komatsuda, Risa Wakisaka, Michihisa Kono, et al.
Head & Neck|February 23, 2024
Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancerMichihisa Kono, Risa Wakisaka, Hiroki Komatsuda, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 22, 2019
Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphomaToshihiro Nagato, Seigo Ueda, Miki Takahara, et al.
Oncoimmunology|January 10, 2022
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinomaMichihisa Kono, Hiroki Komatsuda, Hidekiyo Yamaki, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Head & Neck|October 5, 2020
Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapyMichihisa Kono, Risa Wakisaka, Takumi Kumai, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2023
Cholinergic sensing of allergen exposure by airway epithelium promotes type 2 immunity in the lungsRyusuke Hayashi, Yotesawee Srisomboon, Koji Iijima, et al.
Cancer Research Communications|June 10, 2026
Peptide-reactive T cell response as a novel biomarker in head and neck cancer patients treated with anti-PD-1 antibodyTakumi Kumai, Shota Sakaue, Hisataka Ominato, et al.
Biochemical and Biophysical Research Communications|November 28, 2019
Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinomaShohei Harabuchi, Akemi Kosaka, Yuki Yajima, et al.
Schizophrenia Bulletin|December 21, 2022
Disorganization of Semantic Brain Networks in Schizophrenia Revealed by fMRIYukiko Matsumoto, Satoshi Nishida, Ryusuke Hayashi, et al.
Translational Oncology|February 5, 2022
IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancerMichihisa Kono, Hidekiyo Yamaki, Hiroki Komatsuda, et al.
Cancer Science|October 26, 2022
Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulationHiroki Komatsuda, Risa Wakisaka, Michihisa Kono, et al.
Head & Neck|February 23, 2024
Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancerMichihisa Kono, Risa Wakisaka, Hiroki Komatsuda, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 22, 2019
Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphomaToshihiro Nagato, Seigo Ueda, Miki Takahara, et al.
Oncoimmunology|January 10, 2022
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinomaMichihisa Kono, Hiroki Komatsuda, Hidekiyo Yamaki, et al.
Pageof 5